Search Results - "Cintolo, Jessica A."

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy by Datta, Jashodeep, Berk, Erik, Cintolo, Jessica A, Xu, Shuwen, Roses, Robert E, Czerniecki, Brian J

    Published in Frontiers in immunology (02-06-2015)
    “…Dendritic cells (DC), master antigen-presenting cells that orchestrate interactions between the adaptive and innate immune arms, are increasingly utilized in…”
    Get full text
    Journal Article
  2. 2

    Racial disparities in the use of outpatient mastectomy by Salasky, Vanessa, BA, Yang, Rachel L., BA, Datta, Jashodeep, MD, Graves, Holly L., MD, Cintolo, Jessica A., MD, Meise, Chelsey, BA, Karakousis, Giorgos C., MD, Czerniecki, Brian J., MD, PhD, Kelz, Rachel R., MD

    Published in The Journal of surgical research (2014)
    “…Abstract Background Racial disparities exist within many domains of cancer care. This study was designed to identify differences in the use of outpatient…”
    Get full text
    Journal Article
  3. 3

    Dendritic cell-based vaccines: barriers and opportunities by Cintolo, Jessica A, Datta, Jashodeep, Mathew, Sarah J, Czerniecki, Brian J

    Published in Future oncology (London, England) (01-10-2012)
    “…Dendritic cells (DCs) have several characteristics that make them an ideal vehicle for tumor vaccines, and with the first US FDA-approved DC-based vaccine in…”
    Get more information
    Journal Article
  4. 4

    An International Surgical Rotation as a Systems-Based Elective: The Botswana-University of Pennsylvania Surgical Experience by Cintolo-Gonzalez, Jessica A., MD, Bedada, Alemayehu Ginbo, MD, Morris, Jon, MD, Azzie, Georges, MD

    Published in Journal of surgical education (01-03-2016)
    “…Objective There is a growing need to address the global burden of surgical disease along with increasing interest in international surgical practice,…”
    Get full text
    Journal Article
  5. 5

    Type I-polarized BRAF-pulsed dendritic cells induce antigen-specific CD8+ T cells that impact BRAF-mutant murine melanoma by Cintolo, Jessica A, Datta, Jashodeep, Xu, Shuwen, Gupta, Meera, Somasundaram, Rajasekharan, Czerniecki, Brian J

    Published in Melanoma research (01-02-2016)
    “…Existing therapies targeting the mutated BRAF oncodriver (BRAF(V600E)) successfully treat melanoma but are susceptible to resistance. This study assessed the…”
    Get full text
    Journal Article
  6. 6

    Optimizing dendritic cell-based approaches for cancer immunotherapy by Datta, Jashodeep, Terhune, Julia H, Lowenfeld, Lea, Cintolo, Jessica A, Xu, Shuwen, Roses, Robert E, Czerniecki, Brian J

    Published in The Yale journal of biology & medicine (12-12-2014)
    “…Dendritic cells (DC) are professional antigen-presenting cells uniquely suited for cancer immunotherapy. They induce primary immune responses, potentiate the…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Local Immune Response Predicts Survival in Patients with Thick (T4) Melanomas by Cintolo, Jessica A., Gimotty, Phyllis, Blair, Anne, Guerry, DuPont, Elder, David E., Hammond, Rachel, Elenitsas, Rosalie, Xu, Xiaowei, Fraker, Douglas, Schuchter, Lynn M., Czerniecki, Brian J., Karakousis, Giorgos

    Published in Annals of surgical oncology (01-10-2013)
    “…Background Tumor infiltrating lymphocytes (TIL) and histological regression in primary melanoma are generally considered indicators of the local immune…”
    Get full text
    Journal Article
  9. 9

    Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications by Cintolo-Gonzalez, Jessica A., Braun, Danielle, Blackford, Amanda L., Mazzola, Emanuele, Acar, Ahmet, Plichta, Jennifer K., Griffin, Molly, Hughes, Kevin S.

    Published in Breast cancer research and treatment (01-07-2017)
    “…Numerous models have been developed to quantify the combined effect of various risk factors to predict either risk of developing breast cancer, risk of…”
    Get full text
    Journal Article
  10. 10

    CD4(+) T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8(+) T-cell Targeting of HER2/neu-Expressing Cancers by Datta, Jashodeep, Xu, Shuwen, Rosemblit, Cinthia, Smith, Jenessa B, Cintolo, Jessica A, Powell, Jr, Daniel J, Czerniecki, Brian J

    Published in Cancer immunology research (01-05-2015)
    “…Vaccination strategies incorporating the immunodominant HLA-A2-restricted HER2/neu-derived peptide 369-377 (HER2369-377) are increasingly utilized in…”
    Get more information
    Journal Article
  11. 11

    Intraluminal erosion of laparoscopic gastric band tubing into duodenum with recurrent port-site infections by Cintolo, Jessica A, Levine, Marc S, Huang, Stephanie, Dumon, Kristoffel

    “…Intraluminal erosion of a laparoscopic gastric band into the stomach has been reported as a complication of laparoscopic adjustable gastric banding. To our…”
    Get more information
    Journal Article
  12. 12

    Diagnostic and management challenges for MDM2-, CDK4-negative fatty tumors of the retroperitoneum by Silverstein, Max L., Kalof, Alexandra N., Kurchena, Kathryn C., Harlow, Seth P., Lemos, Diego F., Cintolo-Gonzalez, Jessica A.

    “…Background Neoplasms of the retroperitoneum that contain a major fat component may represent either benign entities, such as lipomas or angiomyolipomas, or…”
    Get full text
    Journal Article
  13. 13
  14. 14